Accessibility Menu
 
Pharvaris logo

Pharvaris

(NASDAQ) PHVS

Current Price$28.55
Market Cap$1.83B
Since IPO (2021)-6%
5 Year+10%
1 Year+81%
1 Month+9%

Pharvaris Financials at a Glance

Market Cap

$1.83B

Revenue (TTM)

$0.00

Net Income (TTM)

$175.70M

EPS (TTM)

$-3.37

P/E Ratio

-8.50

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$28.55

Volume

6,858

Open

$27.92

Previous Close

$28.55

Daily Range

$26.88 - $28.85

52-Week Range

$14.59 - $30.23

PHVS: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharvaris

Industry

Pharmaceuticals

Employees

129

CEO

Berndt A. E. Modig, MBA, CPA

Headquarters

Leiden, 2333 CH, NL

PHVS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-66%

Return on Capital

-31%

Return on Assets

-58%

Earnings Yield

-11.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.83B

Shares Outstanding

64.06M

Volume

6.86K

Short Interest

0.00%

Avg. Volume

160.37K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$169.82M

EBITDA

$169.40M

Operating Cash Flow

$137.07M

Capital Expenditure

$164.62K

Free Cash Flow

$137.24M

Cash & ST Invst.

$291.68M

Total Debt

$776.80K

Pharvaris Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.83B

N/A

Market Cap/Employee

$16.98M

N/A

Employees

108

N/A

Net Income

$46.74M

-26.1%

EBITDA

$47.49M

-33.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$290.90M

+3.9%

Accounts Receivable

$4.55M

+54.6%

Inventory

$0.00

N/A

Long Term Debt

$576.59K

-9.8%

Short Term Debt

$200.21K

-10.0%

Return on Assets

-58.28%

N/A

Return on Invested Capital

-31.43%

N/A

Free Cash Flow

$37.95M

-8.1%

Operating Cash Flow

$37.95M

-8.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCRXBioCryst Pharmaceuticals, Inc.
$8.94+2.05%
NTLAIntellia Therapeutics, Inc.
$13.63-14.11%
IMNMImmunome, Inc.
$23.56+2.48%
ZYMEZymeworks Inc.
$28.10+2.44%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$82.54+0.24%
NOKNokia
$10.46+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.17+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.23-0.09%

Questions About PHVS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.